Substance abuse, including alcohol dependence and abuse, costs society over $500 billion each year. While the healthcare industry has made strides in early identification of alcohol abuse and referral programs, the need for a more strident and targeted therapeutic (pharmacologic) solution remains relatively unmet.

ADial Pharmaceuticals is a leader in developing and commercializing novel prescription medications for addictions and addictive-related behaviors, with a pipeline of innovative products. Each offers promising results for the treatment of substance abuse and addictive behaviors. The lead candidate is AD/TO: 01, a proprietary combination medication that specifically targets alcohol abuse and dependence.

Fast Facts About Alcoholism:

• 3rd leading cause of preventable death and 4th leading cause of disability in the U.S.
• 14 million diagnosed alcohol-dependent/abusers: Same size as depression market 20 years ago, prior to launch of Prozac
• Alcoholism is significantly under-diagnosed and under-treated